Transanal versus Laparoscopic Total Mesorectal Excision in Male Patients with Low Tumor Location after Neoadjuvant Therapy: A Propensity Score-Matched Cohort Study

Table 3

Pathological outcomes.

Characteristics	Group
	taTME()	laTME()
Length of resected intestine in centimeters (cm), (range)	(7.0-34.0)	(6.5-36.0)	0.458
Quality of the mesorectum specimen			0.269
Complete	101 (95.3%)	97 (91.5%)
Nearly complete	5 (4.7%)	9 (8.5%)
Distance between tumor and distal resection margin in cm (range)	(0.1-4.5)	(0.2-4.0)	0.394
Number of harvested lymph nodes, median (range)	13 (1-38)	12 (0-38)	0.285
DRM status, (%)			1
Negative	105 (99.1%)	105 (99.1%)
Positive	1 (0.9%)	1 (0.9%)
Lymphovascular invasion, (%)			0.683
Negative	102 (96.2%)	104 (98.1%)
Positive	4 (3.8%)	2 (5.7%)
Perineural invasion, (%)			0.422
Negative	97 (91.5%)	100 (94.3%)
Positive	9 (8.5%)	6 (5.7%)
CRM status, (%)			0.498
Negative	106 (100%)	104 (98.1%)
Positive	0 (0%)	2 (1.9%)
pT, (%)			0.074
PCR	16 (15.1%)	24 (22.6%)
T1	3 (2.8%)	8 (7.5%)
T2	19 (17.9%)	21 (19.8%)
T3	67 (63.2%)	49 (46.2%)
T4	1 (0.9%)	4 (3.8%)
pN, (%)			0.17
N0	77 (72.6%)	79 (74.5%)
N1	17 (16%)	22 (20.8%)
N2	12 (11.3%)	5 (4.7%)
pM, (%)			0.7213
M0	101 (95.3%)	103 (97.2%)
M1	5 (4.7%)	3 (2.8%)